June 7, 2013
Related News
Other posts that you should not miss.
Positive early data from the BRIDGE1 study, a three-year 1000+ patient study in bronchiectasis funded by the …
June 3, 2019
Dr David Ribeiro, CEO of ProAxsis, will be attending the Bio-Europe Spring meeting, taking place in Barcelona on …
March 6, 2017
ProAxsis was delighted to see its ProteaseTag® technology incorporated in to an important study presented at the …
June 19, 2017
